Scale is about exponential impact. It’s a curve, not a line. Hear me out. The best way to define scale is to look at it ...

Target's digital sales crossed 20% of its total annual merchandise in fiscal 2025. The retailer's revenue from membership and same-day delivery services is surging. The company continues to face ...

Texas House Speaker Dustin Burrows recently released his interim charges, directing legislative committees to review local zoning authority, permitting, housing affordability, public-private ...

Learn about compound interest. We will look at how to determine the final value, initial value, interest rate and years needed. We will investigate problems compounded continuously, daily, weekly, ...

JPMorgan Dividend Leaders ETF (JDIV) holds $9.9M in assets with a 1.59% yield, well below the 4.33% Treasury rate, due to concentrated positions in Taiwan Semiconductor Manufacturing (6.3%), Microsoft ...

In mid-2021, Brown Capital Management Small Company was flying high. Performance was great. Its management team was stable and clicking. Its atypical approach was working well. Sure, the fund was ...

As Florida's legislative session gets closer to a scheduled March 13 end date, Gov. Ron DeSantis better have his veto pen handy. If DeSantis is going to remain true to the principles he's been talking ...

Add Yahoo as a preferred source to see more of our stories on Google. I started paying more attention to the many dishonest ways fitness in general—and strength training especially—is sold to men and ...

BEIJING — China has set an economic growth target of 4.5% to 5% for this year, a slight decrease in the face of a prolonged property slump and other headwinds and uncertainty abroad. The target was ...

Arthur Kroeber, Founding Partner & Head of Research at Gavekal, says he does not expect any surprises from China when it announces its 2026 growth target. That goal, together with a new five-year plan ...

Amphastar Pharmaceuticals remains a 'Hold' as growth and margin headwinds persist amid its transition from generics to a proprietary pipeline. AMPH’s legacy generics are declining, branded products ...